| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 14346 |
| 1 | DEXAMETHASONE | 9020 |
| 2 | DEXAMETHASONE 1.5 MG | 9015 |
| 3 | CYCLOPHOSPHAMIDE | 8053 |
| 4 | LENALIDOMIDE | 7057 |
| 5 | RITUXIMAB | 6443 |
| 6 | CARBOPLATIN | 5495 |
| 7 | PALBOCICLIB | 5380 |
| 8 | METHOTREXATE SODIUM | 5230 |
| 9 | PREDNISONE | 4965 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERIBULIN MESYLATE | 501 | 0.1541 |
| 1 | CLOZAPINE | 14346 | 0.1472 |
| 2 | RIBOCICLIB | 2389 | 0.1276 |
| 3 | DEXRAZOXANE FOR INJECTION | 83 | 0.1191 |
| 4 | DEXRAZOXANE HYDROCHLORIDE | 91 | 0.1155 |
| 5 | TRABECTEDIN | 206 | 0.1106 |
| 6 | VINORELBINE | 591 | 0.1022 |
| 7 | SACITUZUMAB GOVITECAN | 222 | 0.1001 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 221 | 0.0985 |
| 9 | IFOSFAMIDE | 1630 | 0.0980 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 17571 |
| 1 | Atypical Antipsychotic [EPC] | 16476 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 12839 |
| 3 | Platinum-based Drug [EPC] | 12211 |
| 4 | Alkylating Drug [EPC] | 11583 |
| 5 | Kinase Inhibitor [EPC] | 9380 |
| 6 | Thalidomide Analog [EPC] | 9300 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 7430 |
| 8 | Microtubule Inhibitor [EPC] | 6355 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5141 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 4283 | 0.0734 |
| 1 | Estrogen Receptor Antagonist [EPC] | 1728 | 0.0661 |
| 2 | Platinum-based Drug [EPC] | 12211 | 0.0610 |
| 3 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 65 | 0.0607 |
| 4 | Alkylating Drug [EPC] | 11583 | 0.0590 |
| 5 | Actinomycin [EPC] | 135 | 0.0567 |
| 6 | CD30-directed Immunoconjugate [EPC] | 385 | 0.0552 |
| 7 | CD33-directed Immunoconjugate [EPC] | 176 | 0.0543 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 871 | 0.0539 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 304 | 0.0531 |